Life science tools company Partillion Bioscience Corporation announced on Monday that it has started taking pre-orders for its Nanovial Multicell Assay Antibody Discovery Kits.
The Multicell Assay platform, which enables the co-loading of cell pairs to study cell-to-cell interactions, has been named a finalist for the Society for Laboratory Automation and Screening (SLAS) 2025 New Product Award.
At SLAS 2025, Partillion will showcase its Nanovial Multicell Antibody Discovery Kits which leverage larger 50 micrometre diameter EZM Nanovials to enable loading of target cells and antibody-secreting cells together, unlocking the ability to screen hundreds of thousands of antibody secreting cells based on antibody binding on a target cell for therapeutic development.
This platform builds on the success of Partillion's original Nanovial format, which earned the SLAS New Product Award in 2022.
Galapagos plans to wind down cell therapy business following strategic review
Sebela's MIUDELLA Hormone-Free Copper IUS recognised in TIME's best inventions of 2025
Revelation Pharma acquires Acacia Apothecary & Wellness
Viatris receives fifth consecutive recognition on Forbes' annual list of World's Best Employers
INOVIO announces inducement grant to new employee
AbbVie's Allergan Aesthetics announces Natrelle supplier agreement with Vizient
Karyopharm Therapeutics awards inducement grants to new employees
POLYTECH Health & Aesthetics announces Poland expansion
Santhera Pharmaceuticals signs Gulf region distribution agreement with Uniphar